Executive Director, Clinical Pharmacology/Pharmacometrics
Recursion · Remote Opportunity - United Kingdom · London, England · New York, New York · Remote Opportunity - United States · Salt Lake City, Utah
CHECKED 1H AGO
Bio & Science AIremoteexecutive$181k–$221k
At a glance
Highlights
- Lead clinical pharmacology strategy for rare disease and oncology portfolio.
- Use modeling and simulation to solve drug development questions faster.
- Shape Phase 1-3 study designs to get therapies to patients faster.
Ideal candidate
A decisive, collaborative drug development leader with 10+ years experience who thrives in fast-growing biotech and is passionate about delivering therapies for devastating diseases.
Requirements
- Ph.D. in Pharmaceutical Sciences, Pharmacokinetics or related discipline, M.D. with Clinical Pharmacology expertise, or PharmD with Clinical Pharmacology fellowship with 10+ years experience
- Demonstrated success leading all clinical pharmacology aspects of drug development
- Experience managing PK, PK-PD and PK-safety analyses including NCA, population PK modeling and simulations to support dose selection
- Proficiency with WinNonlin, Monolix, NONMEM, R or other modeling software
- Demonstrated experience responding to regulatory agency questions, preparing submissions and attending regulatory meetings
- Experience in oncology preferred
- remote policy
- Remote based in the United Kingdom with periodic travel
Lab profile
About Recursion
AI-native biotech industrializing drug discovery with automation and data to advance oncology and rare disease medicines.
What they build
- Recursion OS drug discovery platform
- Oncology clinical pipeline
- Rare disease clinical pipeline
Known for
- AI-native end-to-end drug discovery
- Computational biology for early discovery
- Clinical development in oncology and rare disease
Key facts
- Founded 2013
- Headquartered in Salt Lake City, Utah
- Public company (Nasdaq: RXRX)